12/09/2024
4:42 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
8:30 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
12/05/2024
3:21 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:06 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:47 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:31 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/14/2024
4:52 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/14/2024
4:47 PM | NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024
3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/13/2024
5:04 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/08/2024
3:43 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
6:24 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:18 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:22 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:15 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
6:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:01 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
8:15 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
7:47 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:49 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:11 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
4:13 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:04 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:23 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:12 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
4:51 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
8:59 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/15/2024
6:22 PM | Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/02/2024
4:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
5:44 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:24 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:49 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:42 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:56 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:59 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:05 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:27 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
4:12 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:15 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:49 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
09/10/2024
3:53 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:50 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:55 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:18 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:10 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
2:08 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:26 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Simson Jake (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:46 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:48 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:08 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024
3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
03/19/2024
6:58 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:01 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Tyra Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2024
3:35 PM | Tyra Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
4:46 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024
4:38 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:40 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:00 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024
6:26 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024
4:10 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024
4:16 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:09 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:22 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:23 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:56 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024
5:05 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:04 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:47 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:24 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
8:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
